We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Mitoxantrone Impurity 1
N-Nitroso Mitoxantrone Impurity 1
CAT No SRC-N0141036
CAS No NA
Mol.F. C22H27N5O7
Mol.Wt. 473.5
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Mitoxantrone Impurity 2
N-Nitroso Mitoxantrone Impurity 2
CAT No SRC-N0141037
CAS No NA
Mol.F. C22H26N6O8
Mol.Wt. 502.5
INV STATUS CUSTOM SYNTHESIS
Cyclophosphamide Nitroso Impurity 1
Cyclophosphamide Nitroso Impurity 1
CAT No SRC-N0141038
CAS No NA
Mol.F. C7H16ClN4O6P
Mol.Wt. 318.7
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Cyclophosphamide USP Related compound D (Possibility 1)
N-Nitroso Cyclophosphamide USP Related compound D (Possibility 1)
CAT No SRC-N0141039
CAS No NA
Mol.F. C7H17ClN3O5P : H2O
Mol.Wt. 289.7 : 18.0
INV STATUS CUSTOM SYNTHESIS
Cyclophosphamide Nitroso Impurity 4
Cyclophosphamide Nitroso Impurity 4
CAT No SRC-N0141041
CAS No NA
Mol.F. C4H9ClN2O2
Mol.Wt. 152.6
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Cyclophosphamide USP Related compound D (Possibility 2)
N-Nitroso Cyclophosphamide USP Related compound D (Possibility 2)
CAT No SRC-N0141042
CAS No NA
Mol.F. C7H17ClN3O5P
Mol.Wt. 289.7
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Cyclophosphamide (hydrate)
N-Nitroso Cyclophosphamide (hydrate)
CAT No SRC-N0141043
CAS No NA
Mol.F. C7H14Cl2N3O3P : H2O
Mol.Wt. 290.1 : 18.0
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Cyclophosphamide USP Related compound B
N-Nitroso Cyclophosphamide USP Related compound B
CAT No SRC-N0141040
CAS No NA
Mol.F. C7H15ClN3O4P
Mol.Wt. 271.6
INV STATUS CUSTOM SYNTHESIS
Plerixafor Nitroso Impurity 1
Plerixafor Nitroso Impurity 1
CAT No SRC-N0141044
CAS No NA
Mol.F. C28H48N14O6
Mol.Wt. 676.8
INV STATUS CUSTOM SYNTHESIS
Plerixafor Nitroso Impurity 2
Plerixafor Nitroso Impurity 2
CAT No SRC-N0141045
CAS No NA
Mol.F. C28H53N9O
Mol.Wt. 531.8
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.